Osmed Formulations Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.14 Cr
as on 16-11-2024
- Company Age 25 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.50 M
as on 16-11-2024
- Revenue 19.53%
(FY 2023)
- Profit 30.28%
(FY 2023)
- Ebitda 9.64%
(FY 2023)
- Net Worth 28.55%
(FY 2023)
- Total Assets 10.64%
(FY 2023)
About Osmed Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.14 Cr.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹5.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Maheshwari and Nipun Maheshwari serve as directors at the Company.
- CIN/LLPIN
U24231MP1999PTC013737
- Company No.
013737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Ujjain, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Osmed Formulations Private Limited offer?
Osmed Formulations Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Common Disease Medicines, Psoriasis Ointment, Marketing Services & Consultants, Marketing Services, Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API, Cardiovascular Drugs & Medication, Blood Pressure Medicine.
Who are the key members and board of directors at Osmed Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nipun Maheshwari  | Whole-Time Director | 05-Aug-2014 | Current |
| Pankaj Maheshwari | Additional Director | 27-May-2024 | Current |
Financial Performance of Osmed Formulations.
Osmed Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.53% increase. The company also saw a substantial improvement in profitability, with a 30.28% increase in profit. The company's net worth Soared by an impressive increase of 28.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Osmed Formulations?
In 2023, Osmed Formulations had a promoter holding of 53.54% and a public holding of 46.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2004 | ₹5.00 Cr | Open |
M. P. Financial Corporation Creation Date: 03 Aug 2007 | ₹2.50 M | Satisfied |
M. P. Financial Corporation Creation Date: 29 Mar 2001 | ₹3.00 M | Satisfied |
How Many Employees Work at Osmed Formulations?
Osmed Formulations has a workforce of 87 employees as of Aug 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osmed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osmed Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
